CD135
preleukemia
leukemogenicity
leukemic
myeloleukemia
acute leukemia
leukemogenically
leukemogenic
leukemoid
chronic leukemia
leukaemic
midostaurin
leukemogenesis
proto-oncogene
promyeloleukemia
tyrosine kinase inhibitor
Fanconi anemia
myelomatosis
gemtuzumab ozogamicin
genotoxin
insertion
biallelism
IGHV
macromutation
myelotomized
omacetaxine
mutate
mutagenize
ultramutation
excrescent
oncoproteogenomic
leukemid
oncomutation
hemoblastosis
antileukemic
oncoproteogenomics
oncoapoptotic
erythroleukemic
acute lymphoblastic leukemia
multimutation
myeloproliferative
premutative
mutative
acute lymphocytic leukemia
myeloleukemic
cytodegenerative
pseudoleukaemia
hypomorph
nonsense mutation
myeloaccumulation
lumiliximab
monocytic leukemia
sarcoglycanopathy
antioncogene
monoblastic leukemia
alemtuzumab
monoblastic leukaemia
monocytic leukaemia
histiocytic leukaemia
mutagenic
histiocytic leukemia
oncogenotype
oncogenetic
hairy cell
quasifixation
mutagenesis
oncogenous
talacotuzumab
point mutation
mutationally
gene mutation
myelomatous
asciminib
mutator
cytodestructive
translesion
hypermutation
insertional mutagenesis
myeloproliferation
leukopenic
anticlastogenic
mutationistic
nonleukemogenic
refractory anaemia with excess blasts
premutagenic
nonleukemic
antimutation
aneupolyploid
epigenotoxic
multiple myeloma
genotoxicology
nonleukemia
idelalisib
nonstop
cancericidal
genetic disorder